title: Pharmacoeconomic Analysis of Micafungin (Mycamine) 100 mg and 150 mg Daily In the Treatment of Candidemia.
abstract: We conducted a retrospective study to assess pharmacoeconomic outcomes of patients who received a daily dose of micafungin 100 mg or 150 mg to treat candidemia. The once-daily 100-mg dose resulted in clinical and mycological outcomes similar to those achieved with 150 mg daily and succeeded in reducing drug-acquisition costs for treating hospitalized patients with candidemia.
authors: Dr. Marfo is Clinical Pharmacy Manager in Solid Organ Transplantation, Department of Pharmacy, at Montefiore Medical Center in Bronx, New York. Dr. Guo is Clinical Pharmacy Manager in Infectious Diseases, Department of Pharmacy, at Montefiore Medical Center.
authors: Kwaku
authors: K
authors: Marfo
authors: Yi
authors: Y
authors: Guo